DUBLIN--(BUSINESS WIRE)--The "Technologies Enabling Nuclear Medicine Imaging" report has been added to ResearchAndMarkets.com's offering.
Nuclear imaging is evolving as a next frontier in the medical imaging industry. Nuclear imaging gained significant importance in medical industry space by understanding physiology of disease that helps in addressing the disease at early stages with faster and accurate diagnosis.
There is an increased adoption of nuclear imaging due to the developments of novel radiopharmaceuticals in new clinical areas like orthopaedics and neurology when compared to traditionally used clinical areas like oncology and cardiology. However, the nuclear imaging industry is poised to face challenges like decreased federal support, heavy regulatory requirements, inadequate supply of radionuclides for research, etc. This report is key for strategies that can be employed the market participants to address the industry challenges.
The analysis would be key for the new entrants and established market players to create viable and implementable strategies to ensure continued innovations and stay competitive in the nuclear imaging industry. This research service sheds light on the nuclear imaging technology landcape, key growth opportunities for research and development, associated regulatory and technology challenges and their corresponding recommendations, key company profiling, and intellectual property landscape.
Key Topics Covered:
1. Executive Summary
2. Technology Snapshot and Trends
- Nuclear Medicine is Key to Understand Biochemical Functioning of Human Organs
- Nuclear Medical Imaging and its Brief overview
- Historical Perspective of Nuclear Medicine Imaging
- Nuclear Medicine Imaging Segmentation
- Nuclear Medicine Segmentation Based on Image Applications
- Radiopharmaceuticals Form the Integral Part of Nuclear Medicine
- Gamma Camera in Nuclear Imaging
- Single photon emission computer tomography (SPECT) in nuclear imaging
- Positron Emission Tomography (PET) in Nuclear Imaging
- Software for Quantification of Nuclear Medicine Imaging Data
3. Drivers and Restraints for Nuclear Medicine Imaging
- Market and Technology Drivers Ranked in Order of Impact (Global), 2018-2024
- Market and Technology Restraints Ranked in Order of Impact (Global), 2018-2024
4. Key Companies and their Innovation Snapshots
- Company Innovation Profiling of Philips Healthcare
- Company Innovation Profiling of General Electric
- Company Innovation Profiling of Siemens Healthineers
5. Emerging Opportunities
- Customizing the Technology Based on Patients' Needs
- Assessing the Efficacy and Biochemical Functioning of New Drugs
- Faster Diagnosis and Increased Availability of Nuclear Medicine
6. Future Research Direction in Nuclear Imaging
- Improving Functionalities will Help Expand Imaging Applications
- Combining Imaging Modalities to Create Multi-modal Scanners
- Need for Innovations in Small Animal Imaging
- Need for Development of Novel Radiotracers
7. Challenges to Advancing Nuclear Medicine and Recommendations
- Federal and Regulatory Challenges in Nuclear Medicine Imaging
- Shortage of Medical Radionuclides and Trained Nuclear Medicine Scientists
8. IP Landscape Analysis
- Nuclear Medicine Imaging - Regional IP Analysis
- Nuclear Medicine Imaging - By Top Assignees
- The US is an Attractive Market and Tops the Chart in Terms of the Number of Technology Innovations Originated
- Patent filings related to Image Reconstruction using Nuclear Medicine
- Patent filing in Operational Methods and Attenuation Compensation in Nuclear Medicine Imaging
- Patents related to Performance Enhancement in Nuclear Medicine Imaging
- Key Patents related to PET Advancements and NM Imaging of Neurodegenerative Diseases
9. Industry Contacts and References
For more information about this report visit https://www.researchandmarkets.com/research/nw74m3/2018_technologies?w=4
